NTRK1 and prostate carcinoma: Otherwise, EPHB4 has been detected in the nucleus of prostate cancer cells [36] and other authors assure that presence of receptor tyrosine kinases in this cell compartment is possible [37] through several mechanisms including receptor internalization upon ligand binding and enzymatic cleavage.